MU
43
-4
BAC
44
-4
MRK
66
3
KO
52
5
VLO
33
-5
TGNA
58
4
BBY
55
-2
GOOG
83
4
BMY
43
8
PRU
50
2
OXY
41
4
ZTS
49
20
HAL
41
11
KMI
55
-4
INTC
47
6
NFLX
69
5
MDT
44
5
CRM
59
4
OI
26
-2
VFC
45
3
MU
43
-4
BAC
44
-4
MRK
66
3
KO
52
5
VLO
33
-5
TGNA
58
4
BBY
55
-2
GOOG
83
4
BMY
43
8
PRU
50
2
OXY
41
4
ZTS
49
20
HAL
41
11
KMI
55
-4
INTC
47
6
NFLX
69
5
MDT
44
5
CRM
59
4
OI
26
-2
VFC
45
3
Financhill
Back

AtriCure Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
49

ATRC
AtriCure

Last Price:
22.03
Seasonality Move:
2.21%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.45
Seasonality Move:
3.65%
Sell
49
AtriCure (ATRC) is a Sell

Is AtriCure a Buy, Sell or Hold?

  • The current AtriCure [ATRC] share price is $22.94. The Score for ATRC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • ATRC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATRC Stock Price Chart

What is AtriCure's stock price today?

  • The AtriCure share price today is $22.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATRC is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

ATRC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 53.37 Buy
Chaikin Money Flow: -217800 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.4 - 23.04) Buy
Bollinger Bands (100): (21.99 - 32.79) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

ATRC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.69 Buy
20-day SMA: 22.11 Buy
50-day SMA: 22.53 Buy
200-day SMA: 32.52 Sell
8-day EMA: 22.06 Buy
20-day EMA: 22.11 Buy
50-day EMA: 23.52 Sell
200-day EMA: 31.45 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

AtriCure Earnings Growth & ATRC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.02 per share, and an increase next year of $0.16 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

AtriCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):